Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study (Q36844513)
Jump to navigation
Jump to search
scientific article published on April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study |
scientific article published on April 2013 |
Statements
1 reference
Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study (English)
1 reference
Michelle Petri
1 reference
Kenneth Kalunian
1 reference
Daniel J Wallace
1 reference
Alberto Spindler
1 reference
Vishala Chindalore
1 reference
Eduardo Mysler
1 reference
C Michael Neuwelt
1 reference
Gabriel Robbie
1 reference
Wendy I White
1 reference
Brandon W Higgs
1 reference
Yihong Yao
1 reference
Liangwei Wang
1 reference
Dominique Ethgen
1 reference
Warren Greth
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference